LanthaGlo – homogeneous assay techniques for inhibitor and antibiotic screening
Bidragets beskrivning
Lack of simple and sensitive assay methodologies have slow down both biological and drug screening studies with different proteins and enzymes. During the recent years, multiple potential target proteins have been identified. However, without the methods to study function of these proteins and ability to target them with modulator molecules, final validation of these target proteins cannot be performed. Recently, many particle-based assay systems have been developed to answer these questions. The project aims not only to develop a novel Eu(III)-particle based homogeneous assay platform to monitor actions of potential drug targets e.g. K-Ras and eIF4A, but also select aptamers to be used as a binder and modulator for these targets. The project will follow a highly translational approach where selected aptamer and developed Eu(III)-particles are used not only to study biological functions but also screening and characterization of allosteric modulators in collaboration with our partners.
Visa merStartår
2019
Slutår
2025
Beviljade finansiering
Andra beslut
353324
Akademiforskarens forskningskostnader(2022)
160 019 €
329012
Akademiforskarens forskningskostnader(2019)
209 996 €
Finansiär
Finlands Akademi
Typ av finansiering
Akademiforskare
Utlysning
Övriga uppgifter
Finansieringsbeslutets nummer
323433
Vetenskapsområden
Kemi
Forskningsområden
Analyyttinen kemia
Identifierade teman
pharmacy, biomedicine